 |
Br J Haematol
- GIRODON F
, Garcon L, Bergoin E, Largier M, et al
Usefulness of the eosin-5'-maleimide cytometric method as a first-line screening test for the diagnosis of hereditary spherocytosis: comparison with ektacytometry and protein electrophoresis.
Br J Haematol. 2008;140:468-70.
PubMed
Related articles
Hemoglobin
- MARX JJ
, Kartikasari AE, Georgiou NA
Can iron chelators influence the progression of atherosclerosis?
Hemoglobin. 2008;32.
PubMed
Related articles
Abstract available
- RAMAZZOTTI A
, Pepe A, Positano V, Scattini B, et al
Standardized T2* map of a normal human heart to correct T2* segmental artefacts; myocardial iron overload and fibrosis in thalassemia intermedia versus thalassemia major patients and electrocardiogram changes in thalassemia major patients.
Hemoglobin. 2008;32.
PubMed
Related articles
Abstract available
- WOOD JC
, Ghugre N
Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases.
Hemoglobin. 2008;32.
PubMed
Related articles
Abstract available
- GOTSIS ED
The uses and differences of r2 and r2* in the determination of iron overload in iron loaded thalassemia patients.
Hemoglobin. 2008;32.
PubMed
Related articles
Abstract available
- AESSOPOS A
, Kati M, Tsironi M
Congestive heart failure and treatment in thalassemia major.
Hemoglobin. 2008;32.
PubMed
Related articles
Abstract available
- PENG CT
, Tsai CH, Wu KH
Effects of chelation therapy on cardiac function improvement in thalassemia patients: literature review and the Taiwanese experience.
Hemoglobin. 2008;32.
PubMed
Related articles
Abstract available
- KOLNAGOU A
, Economides C, Eracleous E, Kontoghiorghes GJ, et al
Long term comparative studies in thalassemia patients treated with deferoxamine or a deferoxamine/deferiprone combination. Identification of effective chelation therapy protocols.
Hemoglobin. 2008;32.
PubMed
Related articles
Abstract available
- TOURKANTONI N
, Athanassiou-Metaxa M, Zafiriou D, Tzimouli V, et al
Immune and neural status of thalassemic patients receiving deferiprone or combined deferiprone and deferoxamine chelation treatment.
Hemoglobin. 2008;32.
PubMed
Related articles
Abstract available
- TSIRONI M
, Assimakopoulos G, Polonofi K, Rigaki K, et al
Effects of combined deferiprone and deferoxamine chelation therapy on iron load indices in beta-thalassemia.
Hemoglobin. 2008;32.
PubMed
Related articles
Abstract available
- KOLNAGOU A
, Michaelides Y, Kontos C, Kyriacou K, et al
Myocyte damage and loss of myofibers is the potential mechanism of iron overload toxicity in congestive cardiac failure in thalassemia. Complete reversal of the cardiomyopathy and normalization of iron load by deferiprone.
Hemoglobin. 2008;32.
PubMed
Related articles
Abstract available
- KONTOGHIORGHES GJ
Ethical issues and risk/benefit assessment of iron chelation therapy: advances with deferiprone/deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox.
Hemoglobin. 2008;32.
PubMed
Related articles
Abstract available
JAMA
- GNECCHI-RUSCONE T
, Rigo F
Normal range for pulmonary artery systolic pressure.
JAMA. 2008;299:2022.
PubMed
Related articles
- MITKA M
New limits advised for anemia drugs.
JAMA. 2008;299:2016.
PubMed
Related articles
|
This E-mail is provided by AMEDEO through an unrestricted educational grant from www.AnaemiaWorld.com, a Roche service.
|